QQQ   444.74 (-0.02%)
AAPL   170.80 (-1.45%)
MSFT   421.11 (-0.08%)
META   489.33 (-0.92%)
GOOGL   150.54 (-0.22%)
AMZN   180.79 (+0.53%)
TSLA   177.68 (-1.20%)
NVDA   906.12 (+0.40%)
NIO   4.63 (-0.86%)
AMD   181.56 (+1.10%)
BABA   72.45 (+1.20%)
T   17.57 (+0.11%)
F   13.23 (+1.30%)
MU   118.36 (-0.65%)
CGC   9.29 (-2.72%)
GE   175.04 (-2.82%)
DIS   122.08 (+0.91%)
AMC   3.80 (-12.44%)
PFE   27.89 (+0.40%)
PYPL   67.14 (+0.86%)
XOM   115.66 (+0.60%)
QQQ   444.74 (-0.02%)
AAPL   170.80 (-1.45%)
MSFT   421.11 (-0.08%)
META   489.33 (-0.92%)
GOOGL   150.54 (-0.22%)
AMZN   180.79 (+0.53%)
TSLA   177.68 (-1.20%)
NVDA   906.12 (+0.40%)
NIO   4.63 (-0.86%)
AMD   181.56 (+1.10%)
BABA   72.45 (+1.20%)
T   17.57 (+0.11%)
F   13.23 (+1.30%)
MU   118.36 (-0.65%)
CGC   9.29 (-2.72%)
GE   175.04 (-2.82%)
DIS   122.08 (+0.91%)
AMC   3.80 (-12.44%)
PFE   27.89 (+0.40%)
PYPL   67.14 (+0.86%)
XOM   115.66 (+0.60%)
QQQ   444.74 (-0.02%)
AAPL   170.80 (-1.45%)
MSFT   421.11 (-0.08%)
META   489.33 (-0.92%)
GOOGL   150.54 (-0.22%)
AMZN   180.79 (+0.53%)
TSLA   177.68 (-1.20%)
NVDA   906.12 (+0.40%)
NIO   4.63 (-0.86%)
AMD   181.56 (+1.10%)
BABA   72.45 (+1.20%)
T   17.57 (+0.11%)
F   13.23 (+1.30%)
MU   118.36 (-0.65%)
CGC   9.29 (-2.72%)
GE   175.04 (-2.82%)
DIS   122.08 (+0.91%)
AMC   3.80 (-12.44%)
PFE   27.89 (+0.40%)
PYPL   67.14 (+0.86%)
XOM   115.66 (+0.60%)
QQQ   444.74 (-0.02%)
AAPL   170.80 (-1.45%)
MSFT   421.11 (-0.08%)
META   489.33 (-0.92%)
GOOGL   150.54 (-0.22%)
AMZN   180.79 (+0.53%)
TSLA   177.68 (-1.20%)
NVDA   906.12 (+0.40%)
NIO   4.63 (-0.86%)
AMD   181.56 (+1.10%)
BABA   72.45 (+1.20%)
T   17.57 (+0.11%)
F   13.23 (+1.30%)
MU   118.36 (-0.65%)
CGC   9.29 (-2.72%)
GE   175.04 (-2.82%)
DIS   122.08 (+0.91%)
AMC   3.80 (-12.44%)
PFE   27.89 (+0.40%)
PYPL   67.14 (+0.86%)
XOM   115.66 (+0.60%)
NASDAQ:AMTX

Aemetis (AMTX) Stock Price, News & Analysis

$6.30
+0.28 (+4.65%)
(As of 10:58 AM ET)
Today's Range
$5.72
$6.47
50-Day Range
$2.89
$6.02
52-Week Range
$1.16
$8.99
Volume
544,364 shs
Average Volume
1.22 million shs
Market Capitalization
$248.91 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$10.30

Aemetis MarketRank™ Stock Analysis

Analyst Rating
Moderate Buy
2.75 Rating Score
Upside/​Downside
71.1% Upside
$10.30 Price Target
Short Interest
Bearish
11.74% of Shares Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
0.79mentions of Aemetis in the last 14 days
Based on 10 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
Growing
From ($1.44) to ($0.24) Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

2.02 out of 5 stars

Oils/Energy Sector

186th out of 242 stocks

Industrial Organic Chemicals Industry

14th out of 19 stocks

AMTX stock logo

About Aemetis Stock (NASDAQ:AMTX)

Aemetis, Inc. operates as a renewable natural gas and renewable fuels company. It operates through three segments: California Ethanol, California Dairy Renewable Natural Gas, and India Biodiesel. The company focuses on the acquisition, development, and commercialization of negative carbon intensity products and technologies that replace traditional petroleum-based products. In addition, it produces and sells ethanol; and wet distillers grains, distillers corn oil, and condensed distillers solubles to dairies and feedlots as animal feed. Further, the company markets and supplies high-grade alcohol and hand sanitizer. Additionally, it researches and develops conversion technologies using waste feedstocks to produce biofuels and biochemicals. Furthermore, it sells biodiesel primarily to government oil marketing companies, transport companies, resellers, distributors, and private refiners through its own sales force and independent sales agents, as well as to brokers who resell the product to end-users. Aemetis, Inc. was founded in 2005 and is headquartered in Cupertino, California.

AMTX Stock Price History

AMTX Stock News Headlines

Aemetis Inc.
Urgent: Protect Your Investments from a Chinese Invasion
An alarming new reality is unfolding across America. The United States is bracing for the unthinkable - a potential Chinese invasion.
Aemetis Target of Unusually Large Options Trading (NASDAQ:AMTX)
Urgent: Protect Your Investments from a Chinese Invasion
An alarming new reality is unfolding across America. The United States is bracing for the unthinkable - a potential Chinese invasion.
AMTX Jan 2025 7.500 put
AMTX May 2024 3.500 call
AMTX Apr 2024 3.500 put
AMTX Mar 2024 3.000 put
When Will Aemetis, Inc. (NASDAQ:AMTX) Breakeven?
AMTX Jul 2024 10.000 put
Aemetis: Q4 Earnings Snapshot
Aemetis's Earnings Outlook
Aemetis: Counting On The Potential
See More Headlines
Receive AMTX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Aemetis and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
3/07/2024
Today
3/28/2024
Next Earnings (Estimated)
5/02/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Industry
Industrial organic chemicals
Sub-Industry
N/A
Current Symbol
NASDAQ:AMTX
Employees
167
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$10.30
High Stock Price Target
$28.00
Low Stock Price Target
$3.00
Potential Upside/Downside
+71.1%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.75
Research Coverage
4 Analysts

Profitability

Net Income
$-46,420,000.00
Pretax Margin
-53.01%

Debt

Sales & Book Value

Annual Sales
$186.72 million
Book Value
($5.76) per share

Miscellaneous

Free Float
33,011,000
Market Cap
$237.85 million
Optionable
Optionable
Beta
0.94
Metaverse Stocks And Why You Can't Ignore Them Cover

Thinking about investing in Meta, Roblox, or Unity? Click the link to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report

AMTX Stock Analysis - Frequently Asked Questions

Should I buy or sell Aemetis stock right now?

4 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Aemetis in the last year. There are currently 1 hold rating and 3 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "moderate buy" AMTX shares.
View AMTX analyst ratings
or view top-rated stocks.

What is Aemetis' stock price target for 2024?

4 equities research analysts have issued 12 month price targets for Aemetis' shares. Their AMTX share price targets range from $3.00 to $28.00. On average, they expect the company's share price to reach $10.30 in the next twelve months. This suggests a possible upside of 71.1% from the stock's current price.
View analysts price targets for AMTX
or view top-rated stocks among Wall Street analysts.

How have AMTX shares performed in 2024?

Aemetis' stock was trading at $5.24 at the beginning of 2024. Since then, AMTX stock has increased by 14.9% and is now trading at $6.02.
View the best growth stocks for 2024 here
.

When is Aemetis' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, May 2nd 2024.
View our AMTX earnings forecast
.

How were Aemetis' earnings last quarter?

Aemetis, Inc. (NASDAQ:AMTX) released its quarterly earnings results on Thursday, March, 7th. The specialty chemicals company reported ($0.34) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.35) by $0.01. The specialty chemicals company earned $70.76 million during the quarter, compared to analyst estimates of $80.08 million. During the same quarter last year, the company posted ($0.63) EPS.

What ETF holds Aemetis' stock?

Invesco Dorsey Wright Energy Momentum ETF holds 189,235 shares of AMTX stock, representing 1.60% of its portfolio.

What other stocks do shareholders of Aemetis own?
Who are Aemetis' major shareholders?

Aemetis' stock is owned by a number of retail and institutional investors. Top institutional shareholders include Vanguard Group Inc. (4.27%), Vanguard Group Inc. (4.27%), Stifel Financial Corp (1.74%), Citadel Advisors LLC (0.00%), Cannell Capital LLC (0.00%) and Bridgeway Capital Management LLC (0.23%). Insiders that own company stock include Andrew B Foster, Andrew B Foster, Francis P Barton, John R Block, John R Block, Naomi Louise Boness, Sanjeev Gupta, Timothy Alan Simon and Todd Waltz.
View institutional ownership trends
.

How do I buy shares of Aemetis?

Shares of AMTX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:AMTX) was last updated on 3/28/2024 by MarketBeat.com Staff

From Our Partners